Search
for
Sort by
Research 61–90 of 474
- Alopecia areata
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Immunopathogenesis of Primary Cicatricial Alopecia
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Novel therapies for alopecia areata: The era of rational drug development
- Janus Kinase inhibitors in dermatology: a review
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Application and progress of induced pluripotent stem in chronic wound healing: a narrative review
- Lipid nanocarriers as innovative strategies for hair regrowth
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Pro-inflammatory Vδ1+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles
- Hair follicle immune privilege and its collapse in alopecia areata
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Maintenance of Barrier Tissue Integrity by Unconventional Lymphocytes
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Immune therapies for alopecia areata: evidence and new perspectives
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Dietary Habits in Japanese Patients with Alopecia Areata
- Alopecia areata: medical treatments